中文

Elevance Health, Inc. Revenue Breakdown

Period 2026-06-30 (quarterly) ・ Reported 2026-07-15
ItemAmountY/Y
Revenue$50.47B+1.4%
Gross profit$44.98B
Operating income$1.76B
Net income$1.46B-16.1%
Gross margin89.1%Net margin 2.9%
Revenue Q/Q+0.6%

Revenue Segments

SegmentRevenueShare
Product$6.26B12.4%
Service Fees$2.28B4.5%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue$5.49B10.9%
SG&A$5.55B11.0%
Tax & other$0.30B0.6%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

EMEEMRETREOGEQTEFXEQIXEQRERIEESSELEG

Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies